List of Cirdan Ultra LIS Customers
Cirdan Ultra
Riverbank, The Green, Tullynacross Road, Lambeg,
Lisburn, BT27 5SR,
United Kingdom
Lisburn, BT27 5SR,
United Kingdom
44 28 9266-0880
Professional Services
100
$10M
Since 2010, our global team of researchers has been studying Cirdan Ultra LIS customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Cirdan Ultra LIS for Laboratory Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Cirdan Ultra LIS for Laboratory Management include: Sherwood Forest Hospitals United Kingdom, a United Kingdom based Healthcare organisation with 5849 employees and revenues of $597.0 million, Australian Clinical Labs, a Australia based Healthcare organisation with 4900 employees and revenues of $446.0 million, Australian Centre for the Prevention of Cervical Cancer, a Australia based Non Profit organisation with 200 employees and revenues of $20.0 million, National Blood Authority Australia, a Australia based Government organisation with 97 employees and revenues of $16.0 million and many others.
Contact us if you need a completed and verified list of companies using Cirdan Ultra LIS, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Cirdan Ultra LIS customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Australian Centre for the Prevention of Cervical Cancer | Non Profit | 200 | $20M | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2024 | n/a |
In 2024 the Australian Centre for the Prevention of Cervical Cancer implemented Cirdan Ultra LIS from Cirdan Imaging to modernise its pathology division VCS Pathology. The deployment, announced by Cirdan in May 2024, targeted centralised Laboratory Management for HPV and cervical screening workflows across ACPCC.
Cirdan Ultra LIS was configured to deliver core laboratory management capabilities including sample accessioning and tracking, structured data management, quality control workflows and consolidated reporting orchestration. Configuration emphasized workflow automation, role based access controls and standardized laboratory procedures to support pathology operations and quality assurance activities.
Operational scope covered ACPCC's pathology division and VCS Pathology sites and extended support for cervical cancer prevention workflows in Australia and the Indo Pacific. The implementation established a centralised digital environment to streamline sample and data flows and to consolidate quality control and reporting processes for HPV screening.
Rollout and governance were executed throughout 2024 with phased adoption across the pathology division, aligning laboratory procedures to the new system and formalizing standard operating workflows for screening and reporting. The program focused on consolidating data governance and operational workflows within the Cirdan Ultra LIS deployment rather than on external integration specifics.
|
 |
Australian Clinical Labs | Healthcare | 4900 | $446M | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2018 | n/a |
In 2018, Australian Clinical Labs implemented Cirdan Ultra LIS as part of a program to operate a single national Laboratory Management system. The deployment focused on South Western Victoria, with Portland and Warrnambool going live on 1 September 2018, and Geelong and Colac going live on 17 November 2018, consolidating regional laboratories onto the Cirdan Ultra LIS platform.
Cirdan Ultra LIS was configured to deliver core Laboratory Management functionality, including specimen accessioning, electronic test ordering, results management and reporting, patient demographic and history access, and configurable pathology sign‑out workflows. The implementation emphasized workflow configuration to support local pathology practice and to enable remote specialist review and sign‑off by the national pathology network.
Operationally the project completed Australian Clinical Labs’ national program to replace LabTrak, with LabTrak preserved as an archived system for patient history reference from the listed cutover dates. The move to Cirdan Ultra LIS centralized laboratory information management across the company’s sites in Victoria’s South West, and it was positioned to improve access to the expertise of over 95 specialist pathologists across Australia.
Governance and rollout were executed on a staged weekend cutover schedule to minimize impact on referrers and patients, and Clinical Labs produced a companion booklet for referrers and practice managers to support the change. The deployment standardized Laboratory Management processes across the region, archived prior patient histories in LabTrak for reference, and explicitly enabled broader specialist pathology collaboration across the national estate.
|
 |
National Blood Authority Australia | Government | 97 | $16M | Australia | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2015 | n/a |
In 2015 National Blood Authority Australia implemented Cirdan Ultra LIS. The project was announced in December 2015 as the first comprehensive Laboratory Management system to fully interface with Australia’s BloodNet, explicitly targeting transfusion and blood-supply workflows.
Cirdan Ultra LIS provided laboratory management capabilities focused on blood inventory and transfusion management, delivering real-time data exchange to participating sites and reducing manual data entry. The Cirdan Ultra LIS deployment centralized electronic exchange of inventory and transfusion records, improving data quality for blood stock and patient transfusion events.
The implementation established a direct integration between Cirdan Ultra LIS and Australia’s BloodNet, enabling synchronous updates across participating laboratories in Australia. The integration announcement occurred in December 2015 and rollout across sites completed in the months following the announcement, covering transfusion services and blood bank operations.
Governance adjustments emphasized standardized transfusion workflows and data exchange protocols across sites to support consistent inventory reporting and patient safety processes. Outcomes reported with the Cirdan Ultra LIS integration included reduced manual data entry and improved data quality for blood inventory and transfusion management.
|
 |
Sherwood Forest Hospitals United Kingdom | Healthcare | 5849 | $597M | United Kingdom | Cirdan Imaging | Cirdan Ultra LIS | Laboratory Management | 2024 | n/a |
In 2024 Sherwood Forest Hospitals United Kingdom selected Cirdan Ultra LIS from Cirdan Imaging for its Cellular Pathology service, using the Laboratory Management application to modernize pathology reporting and workflow orchestration. The implementation targeted Cellular Pathology to standardize case tracking and reporting processes across the trust.
Deployment included migration of historical patient data into Cirdan Ultra LIS and configuration of core Laboratory Management capabilities such as case management, slide and block tracking, report authoring and workflow automation for specimen accessioning and sign out. The project emphasized data validation cycles and configuration to reflect cellular pathology workflows and role based access for pathologists and biomedical scientists.
Integrations were delivered with downstream systems ICE, Infoflex and Labcomms to enable electronic requesting, result routing and downstream notifications, with interfaces designed to support bidirectional exchange and result dissemination across clinical teams. Operational coverage focused on the Cellular Pathology department while providing hospital wide connectivity for pathologists, laboratory staff and requesting clinicians.
Go-live for Cellular Pathology occurred in late April 2025 and post go-live activity reported efficiencies and positive user feedback according to the project source. Governance and rollout used phased cutover and migration validation to preserve historical patient data integrity and maintain continuity of pathology reporting workflows.
|
Showing 1 to 4 of 4 entries
Buyer Intent: Companies Evaluating Cirdan Ultra LIS
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Cirdan Ultra LIS. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Cirdan Ultra LIS for Laboratory Management include:
- NHS, a United Kingdom based Healthcare organization with 1297455 Employees
- Nuffield Health, a United Kingdom based Healthcare company with 16400 Employees
- Mater Health, a Australia based Non Profit organization with 10000 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||
FAQ - APPS RUN THE WORLD Cirdan Ultra LIS Coverage
Cirdan Ultra LIS is a Laboratory Management solution from Cirdan Imaging.
Companies worldwide use Cirdan Ultra LIS, from small firms to large enterprises across 21+ industries.
Organizations such as Sherwood Forest Hospitals United Kingdom, Australian Clinical Labs, Australian Centre for the Prevention of Cervical Cancer and National Blood Authority Australia are recorded users of
Cirdan Ultra LIS for Laboratory Management.
Companies using Cirdan Ultra LIS are most concentrated in Healthcare, Non Profit and Government, with adoption spanning over 21 industries.
Companies using Cirdan Ultra LIS are most concentrated in United Kingdom and Australia, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Cirdan Ultra LIS across Americas, EMEA, and APAC.
Companies using Cirdan Ultra LIS range from small businesses with 0-100 employees - 25%, to mid-sized firms with 101-1,000 employees - 25%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 0%.
Customers of Cirdan Ultra LIS include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Cirdan Ultra LIS customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Laboratory Management.